At Intercept, our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases. Intercept’s lead product, obeticholic acid (OCA), is a first-in-class farnesoid X receptor (FXR) agonist. OCA, marketed under the brand name “Ocaliva®,” is approved in the U.S., EU and Canada for certain patients with primary biliary cholangitis (PBC), a rare autoimmune liver disease. Ocaliva® was the first product to be approved for PBC in over twenty years and our team is proud to have been pioneers in providing the first second-line treatment option to patients with such critical need. The Ocaliva® launch in 2016 also marked Intercept’s successful transition from a development-stage company to a fully integrated commercial organization with continued growth.
In February 2019, Intercept reported positive topline results from the Phase 3 REGENERATE study of OCA in patients with liver fibrosis due to nonalcoholic steatohepatitis (NASH). REGENERATE is the first and largest Phase 3 study in NASH – a chronic disease that threatens the lives of millions of people in the U.S. alone. Currently, there are no available treatments for NASH, and Intercept is among the leading companies focused on the disease.
Based on the positive results from REGENERATE, Intercept submitted the first new drug application for a NASH treatment to the U.S. FDA in September 2019. This is an exciting time for Intercept, as the organization prepares for a potential approval and launch in NASH. As part of this effort, Intercept is beginning to build a new commercial organization, and this opportunity for a Regional Sales Manager, South Germany will play a pivotal role in preparing the company for the successful anticipated launch of OCA’s second indication.
Reporting to the National Sales Director, Germany, the Regional Sales Manager, South Germany is key for the implementation, execution, monitoring and managing of our commercial sales strategy in the field and the improvement of our operational sales effectiveness capabilities. The Regional Sales Manager accomplishes sales human resource objectives by recruiting, selecting, orienting, training, assigning, scheduling, coaching, counseling, and disciplining employees in assigned districts. Achieving sales operational objectives by contributing sales information and recommendations to strategic plans and reviews as well as preparing and completing action and key account plans is of pivotal importance. The Regional Sales Manager is also responsible for identification, creating, managing and implementing SFE effectiveness improvements and projects to increase sales force intelligence and excellence in the team. The successful candidate is capable of working in an international and multicultural environment to help drive the success of the company. He or she should be analytical, confident, diplomatic, independent and entrepreneurial with excellent IT-knowledge and is also part of the local commercial leadership team in the country. He/she creates, develops and drives national strategies and tactics and ensures a close x-functional collaboration with medical, marketing, corporate affairs and market access in an exemplary manner.
The successful candidate must be able to perform each of the following satisfactorily:
REQUIRED KNOWLEDGE AND ABILITIES:
Most of the time is spent with field employees and customers and regular head office travelling to Munich. Almost daily travel is required within Germany but also to the International Head Office in London (quarterly).
Field based with a focus in the South part of Germany with an excellent travel infrastructure
This is a unique opportunity to join Intercept at an exciting time as we prepare for our next potential product launch, and to play a key role in the success of our expansion in Germany. Excellent remuneration package.
To apply, please send an up-to-date CV and cover letter in English